335 related articles for article (PubMed ID: 37931207)
1. Causes and consequences of clonal hematopoiesis.
Weeks LD; Ebert BL
Blood; 2023 Dec; 142(26):2235-2246. PubMed ID: 37931207
[TBL] [Abstract][Full Text] [Related]
2. Clonal Hematopoiesis and Premalignant Diseases.
Kaner J; Desai P; Mencia-Trinchant N; Guzman ML; Roboz GJ; Hassane DC
Cold Spring Harb Perspect Med; 2020 Apr; 10(4):. PubMed ID: 31615870
[TBL] [Abstract][Full Text] [Related]
3. Distinction of lymphoid and myeloid clonal hematopoiesis.
Niroula A; Sekar A; Murakami MA; Trinder M; Agrawal M; Wong WJ; Bick AG; Uddin MM; Gibson CJ; Griffin GK; Honigberg MC; Zekavat SM; Paruchuri K; Natarajan P; Ebert BL
Nat Med; 2021 Nov; 27(11):1921-1927. PubMed ID: 34663986
[TBL] [Abstract][Full Text] [Related]
4. Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment.
von Beck K; von Beck T; Ferrell PB; Bick AG; Kishtagari A
Blood Cancer J; 2023 Jan; 13(1):5. PubMed ID: 36599826
[TBL] [Abstract][Full Text] [Related]
5. [Importance of clonal hematopoiesis for hematologic neoplasms].
Götze KS; Lengerke C
Inn Med (Heidelb); 2022 Nov; 63(11):1107-1114. PubMed ID: 36125513
[TBL] [Abstract][Full Text] [Related]
6. The Origin of Clonal Hematopoiesis and Its Implication in Human Diseases.
Zhang Z; Sun J
Adv Exp Med Biol; 2023; 1442():65-83. PubMed ID: 38228959
[TBL] [Abstract][Full Text] [Related]
7. Clonal hematopoiesis and inflammation: A review of mechanisms and clinical implications.
Nathan DI; Dougherty M; Bhatta M; Mascarenhas J; Marcellino BK
Crit Rev Oncol Hematol; 2023 Dec; 192():104187. PubMed ID: 37879493
[TBL] [Abstract][Full Text] [Related]
8. Clonal Hematopoiesis: Origins and determinants of evolution.
Mendez LM; Patnaik MM
Leuk Res; 2023 Jun; 129():107076. PubMed ID: 37075557
[TBL] [Abstract][Full Text] [Related]
9. Clonal hematopoiesis and its impact on the aging osteo-hematopoietic niche.
Winter S; Götze KS; Hecker JS; Metzeler KH; Guezguez B; Woods K; Medyouf H; Schäffer A; Schmitz M; Wehner R; Glauche I; Roeder I; Rauner M; Hofbauer LC; Platzbecker U
Leukemia; 2024 May; 38(5):936-946. PubMed ID: 38514772
[TBL] [Abstract][Full Text] [Related]
10. ASXL1 mutation in clonal hematopoiesis.
Fujino T; Kitamura T
Exp Hematol; 2020 Mar; 83():74-84. PubMed ID: 31945396
[TBL] [Abstract][Full Text] [Related]
11. Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies.
Ye B; Sheng Y; Zhang M; Hu Y; Huang H
Cancer Lett; 2022 Jul; 538():215691. PubMed ID: 35469959
[TBL] [Abstract][Full Text] [Related]
12. Advances in understanding the molecular basis of clonal hematopoiesis.
Alagpulinsa DA; Toribio MP; Alhallak I; Shmookler Reis RJ
Trends Mol Med; 2022 May; 28(5):360-377. PubMed ID: 35341686
[TBL] [Abstract][Full Text] [Related]
13. Clonal hematopoiesis: Molecular and clinical implications.
Kusne Y; Xie Z; Patnaik MM
Leuk Res; 2022 Feb; 113():106787. PubMed ID: 35091334
[TBL] [Abstract][Full Text] [Related]
14. Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation.
Goldman EA; Spellman PT; Agarwal A
Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 36889927
[TBL] [Abstract][Full Text] [Related]
15. How low can you go?: Methodologic considerations in clonal hematopoiesis variant calling.
Beeler JS; Bolton KL
Leuk Res; 2023 Dec; 135():107419. PubMed ID: 37956474
[TBL] [Abstract][Full Text] [Related]
16. Germline predisposition for clonal hematopoiesis.
Kubota Y; Viny AD
Semin Hematol; 2024 Feb; 61(1):61-67. PubMed ID: 38311514
[TBL] [Abstract][Full Text] [Related]
17. Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies.
Bowman RL; Busque L; Levine RL
Cell Stem Cell; 2018 Feb; 22(2):157-170. PubMed ID: 29395053
[TBL] [Abstract][Full Text] [Related]
18. Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities.
Younes IE; Syler L; Hamed A
Leuk Res; 2023 Jul; 130():107307. PubMed ID: 37186988
[TBL] [Abstract][Full Text] [Related]
19. Clinical manifestations of clonal hematopoiesis: What has SF3B1-mutant MDS taught us?
Todisco G; Moura PL; Hellström-Lindberg E
Semin Hematol; 2022 Jul; 59(3):150-155. PubMed ID: 36115692
[TBL] [Abstract][Full Text] [Related]
20. High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancer.
Stonestrom AJ; Menghrajani KN; Devlin SM; Franch-Expósito S; Ptashkin RN; Patel SY; Spitzer B; Wu X; Jee J; Sánchez Vela P; Milbank JH; Shah RH; Mohanty AS; Brannon AR; Xiao W; Berger MF; Mantha S; Levine RL
Blood Adv; 2024 Feb; 8(4):846-856. PubMed ID: 38147626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]